arrow
F

Franco Noventa

quovadis no-profit association
H指数:44
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Rationale and Design of the PREDICT-CCM Study: Predictive Value of Dobutamine Stress Echocardiography for Clinical Response to Cardiac Contractility Modulation Therapy in a Multicenter Italian Cohort

PREDICT-CCM研究的原理与设计:多中心意大利队列中心肌收缩力调节治疗临床反应的多巴酚丁胺应激超声心动图预测价值

2026-04-230
OAAI
The PhysioVP-AF study, a randomized controlled trial to assess the clinical benefit of physiological ventricular pacing vs. managed ventricular pacing for persistent atrial fibrillation prevention in patients with prolonged atrioventricular conduction: design and rationale
2023-03-283
OAAI
Prevalence of pulmonary embolism among patients with recent onset of dyspnea on exertion. A cross-sectional study

近期劳力呼吸困难患者中肺栓塞的患病率。一项横断面研究

2023-01-013
OAAI
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort
2020-02-0315
PREAI
Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study
2020-02-0114
PREAI
Impact of HBV infection in HCV/HBV coinfected patients treated with DAAs IN Northern Italy
2020-02-010
PREAI
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure
2019-12-0171
PREAI
Efficacy and safety of elbasvir/grazoprevir in a large real-life cohort of HCV-infected patients
2019-04-011
PREAI
Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir for retreatment of chronic hepatitis C patients with a previous failure to direct-acting antivirals: A real-life study from the NAVIGATORE Lombardia and Veneto Networks
2019-04-011
PREAI
Treatment of 320 genotype 3 cirrhotic patients with 12 weeks of sofosbuvir/velpatasvir with or without ribavirin: Real life experience from Italy
2019-04-011
PREAI
Renal safety in 3, 264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study
2019-04-010
PREAI
Treatment of genotype 3 HCV infection in the large real-life Navigatore Lombardia multicentre cohort: Results from three different regimens
2019-04-011
PREAI
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C

glecaprevir/pibrentasvir在723例慢性丙型肝炎患者中的真实世界有效性和安全性

2019-03-01103
PREAI
Efficacy and safety of Elbasvir/Grazoprevir in a large real-life cohort of HCV-infected patients
2019-02-010
PREAI